Browse Category

Analyst Ratings News 8 October 2025 - 28 October 2025

Visa (V) Stock Poised for a Surge? Crypto Pilot and Travel Deals Fuel Optimism

Visa Stock Jumps on Earnings Beat and Dividend Hike – Analysts Bullish on $400 Target

Visa’s Stock Rallies After Earnings and Dividend Hike Visa’s latest earnings report delivered plenty for investors to cheer. The company’s fiscal fourth-quarter results (for the quarter ended September 30, 2025) beat expectations on both the top and bottom line. Net

28 October 2025

Clover Health (CLOV) Stock Soars 18% on Analyst Upgrades, Unusual Options Buzz

Stock Performance: Clover Health stock has been exceptionally volatile in mid‑October 2025. On Oct. 21 it jumped ~8.7% intraday to ~$3.20 marketbeat.com (from $2.92 prior close), and on Oct. 24 it spiked another ~18%, trading near $3.79 (from $3.20 close

24 October 2025

Analyst Ratings · Financial Analysis · Investment News · NASDAQ:CLOV · Options Trading · Stock Market

Sunrun (RUN) Stock Soars 5% to 12-Month High on Analyst Upgrades and Solar Incentives

Stock Rallies on Upbeat Sentiment On Oct. 21, 2025, Sunrun (Nasdaq: RUN) traded around $20.50, up about 5% intraday reuters.com. This surge followed news that Wall Street’s Citigroup had upgraded Sunrun to “Buy” with a $26 price target marketbeat.com. The

21 October 2025

Analyst Ratings · Investment News · NASDAQ:RUN · Renewable Energy · Solar Power · Stock Market

iBio Stock Surges on Bullish Analyst Calls and Obesity Drug Breakthroughs

IBIO Stock Price and Recent Volatility As of midday October 21, 2025, iBio’s stock (NASDAQ: IBIO) trades around $0.89 per share marketbeat.com. The price has been volatile in recent days. Last week, shares jumped over 20% in pre-market trading on

21 October 2025

Analyst Ratings · Biotech · Obesity Research · Pharmaceuticals · Stock News

Beam Therapeutics Stock Soars on FDA Backing – Analysts Forecast ~70% Upside

Ticker: Beam Therapeutics (NASDAQ: BEAM) globenewswire.com. – Price (Oct 21, 2025): ~$30 per share (about +17% recently) ts2.tech. – Sector: Biotechnology (precision gene editing) globenewswire.com. – Recent News: FDA granted Regenerative Medicine Advanced Therapy (RMAT) and Orphan Drug designations to

21 October 2025

Analyst Ratings · Biotechnology · Healthcare · Investment · NASDAQ:BEAM · Stock Market

SoFi’s Roller-Coaster Rally: Fintech Stock Soars 230% in 2025 – What’s Next for SOFI?

SoFi Stock Surges on Analyst Upgrade and $1.6 Trillion Fintech Opportunity

Stock Rebound After Volatile Weeks SoFi’s stock has been on a roller-coaster. After tripling in the past year, climbing from single-digit prices to a record ~$30 in late September, the fintech favorite hit turbulence ts2.tech. In the final weeks of

20 October 2025

Analyst Ratings · Financial News · Fintech · Investment · NASDAQ:SOFI · Stock Market

Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Stock Jumps as Outlook Brightens Gilead’s share price has been on a tear in recent weeks, reaching new highs for 2025. By mid-day October 17, GILD was up about 4.7% to roughly $123 per share benzinga.com. Year-to-date, the stock has

17 October 2025

Analyst Ratings · Biotechnology · HIV Research · Patent News · Stock Market

Broadcom’s $10B AI Chip Deal Ignites Stock Surge – What’s Powering This Tech Giant’s Boom

Broadcom (AVGO) Stock Soars After $10B OpenAI AI Chip Deal – Analysts Raise Targets

Stock Performance and Recent Movement Broadcom’s stock has surged dramatically in 2023–2025, fueled by the AI boom and strategic deals ts2.tech. After a 10-for-1 split in Feb 2024, retail interest surged along with its fundamentals ts2.tech. By Oct 2025, Broadcom’s

17 October 2025

AI Industry · Analyst Ratings · Business News · NASDAQ:AVGO · Semiconductors · Stock Market

Lockheed Martin News Roundup (Oct 1–10, 2025): Defense Giant Navigates New Contracts, Space Ambitions, and Market Momentum

Lockheed Martin (LMT) Stock Rises on $11B Navy Contract, Dividend Hike & Analyst Upgrades

Stock Performance Today and Recent Trend Lockheed’s stock opened around $504.8 on Oct. 15, 2025 and is roughly flat on the day marketbeat.com. Over the past week it has seen minor fluctuation but remains in a broad trading range. After

15 October 2025

Analyst Ratings · Company Contracts · Defense Industry · Dividend Investing · NYSE:LMT · Stock Market News

Canadian Solar (CSIQ) Stock Skyrockets: Analyst Upgrade & Battery Boom Ignite Rally

Stock Rally and Analyst Buzz Canadian Solar’s stock has surged sharply this week. On Oct 14 its share price hit a 52-week high of around $16.00 before closing at $15.72 marketbeat.com. This spike was driven by two main headlines: Goldman

15 October 2025

Analyst Ratings · Battery Technology · Investment News · NASDAQ:CSIQ · Renewable Energy · Stock Market

PNC Financial Stock Oversold – Q3 Earnings Beat & Analyst Upgrades Fuel Rebound Hopes

Current Stock Performance & Technical Signals As of mid-October 2025, PNC stock is trading around the $190 level, having recovered from a brief dip into the mid-$180s. The share price is roughly 3.5% lower over the past quarter and basically

15 October 2025

Analyst Ratings · Earnings Reports · Financial News · Investment Strategies · NYSE:PNC · Stock Market

UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

Current Stock Price and Performance (Oct 8 2025) UnitedHealth Group’s share price has been volatile in 2025. On 8 Oct 2025 the stock closed around $372—IndMoney quoted $372.93 while Investing.com listed $372.64 indmoney.com investing.com. Reuters reported that the last trade was $371.46, up 2.15 %

8 October 2025

Analyst Ratings · Investing · NYSE:UNH · Stock Market · UNH · Wall Street

Previous 1 … 10 11 12 13 Next

Go toTop